top
mobile menu button
 
A+ -A Français Make a Payment
Search Arrow

Exclusively Available through Dynacare

ATN Profile

Get clearer answers and a faster diagnosis for Alzheimer’s disease

This advanced, non-invasive blood test can help shorten the time to diagnose Alzheimer’s disease.

Download requisition

What is Alzheimer’s Disease

Alzheimer’s is the most common form of dementia. Its symptoms vary but may start with mild memory loss or difficulty remembering words or names. As it progresses, Alzheimer’s causes worsening confusion and memory loss, changes in personality, the inability to perform everyday tasks and more.

Alzheimer’s is caused by a slow build-up of protein plaques and tangles in the brain that eventually cause brain cells to stop working properly. This build-up usually starts years before a person experiences symptoms. Alzheimer’s-related memory loss is caused by brain cells working improperly and dying-a process known as neurodegeneration.

Diagnosing Alzheimer’s Disease

Until recently, it has been difficult to identify the biological changes that indicate Alzheimer’s. The typical evaluation, which includes physical exam, blood and urine tests and cognitive testing may provide ambiguous or conflicting answers, which can result in delayed referrals until symptoms become clearer.

The good news is that has changed with new technology and testing.

The ATN Profile

Exclusively Available from Dynacare

The ATN Profile helps doctors detect evidence of biological changes consistent with Alzheimer’s. These tests are the first objective tools that doctors have to help evaluate Alzheimer’s, meaning that with a simple blood test, your provider can get a clearer answers on Alzheimer’s and its progression and get patients on a care plan earlier.

What is ATN?

ATN is a classification system established by the Alzheimer’s research community that groups various biomarkers for Alzheimer’s into three categories that look for evidence of biological changes. A profile is a test that looks at multiple biomarkers at the same time.

Represents amyloid, and categorizes tests associated with detecting amyloid plaques, which are a hallmark of Alzheimer’s disease.

Represents tau, and categorizes tests associated with detecting tau tangles, which is a second hallmark of Alzheimer’s disease.

Represents neurodegeneration, and categorizes tests associated with determining whether a patient’s brain cells are dying. Unlike ‘A’ and ’T’ markers, ’N’ markers determine disease severity

By looking at all three of these biomarkers together, the Dynacare ATN Profile provides you and your doctor clear and measurable insight into Alzheimer’s-related changes in the body.

How to Get the ATN Panel

The ATN Panel is exclusively available from Dynacare. This simple blood test must be ordered through a healthcare provider.

The ATN Profile may be right for you if you or a loved one has had a clinical assessment for dementia and your physician/a clinician has determined additional testing/assessments are needed.

The results from the test can help accelerate the path to diagnosis, giving you or your loved one access to earlier treatment and more time to make important decisions.

Ask your healthcare provider if the
Dynacare ATN Profile is right for you.

Understand your ATN Panel Results

Blood testing for Alzheimer’s disease and other dementias is not yet a perfect science. These tests are available to help your doctor determine if follow-up testing is necessary.

Follow-up testing is intended to confirm a diagnosis, so be careful not to make assumptions or plans based on the results of the ATN Profile. These follow-up tests are much more invasive and expensive, which is why the blood-based ATN Profile is a viable first option to assess whether biological changes associated with dementia and Alzheimer’s are present.

In general, dementia and Alzheimer’s testing is complicated; be sure to have thorough conversations with your doctors about all your results.

Other Genetic Tests We Offer

Genecept Assay® for Pharmacogenomic Testing

OptimalRx Plus® for Pharmacogenomic Testing

The Genecept Assay tests 18 genes relevant for psychiatric treatment planning with the aim of choosing medications that reduce unwanted side effects and are more likely to be safe and effective.

Hemoglobinopathy Screening Program

Hemoglobinopathy Screening Program

Dynacare has created a pathway for comprehensive hemoglobinopathy screening including molecular testing and genetic counselling for the province of Ontario.

Color Test for Hereditary Cancer Screening

Color Test for Hereditary Cancer Screening

Color analyzes 30 genes – including BRCA1 and BRCA2 – to help women and men understand their risk for the most common hereditary cancers, including breast, ovarian, colorectal, pancreatic and other cancers.